From the Toronto Star:
High-stakes showdown
While PhRMA members Pfizer Inc., GlaxoSmithKline PLC, AstraZeneca PLC and Wyeth Co. have each gone to extraordinary lengths in attempting to limit supply of their products to Canadian pharmacies that promise not to engage in cross-border sales, at the same time they try to make light of the estimated 1 million Americans now said to be buying close to $1 billion worth of prescription drugs from the Canadian discounters.

From the San Mateo County (CA) Times:
U.S. drug industry throttling Canada's Internet pharmacies
Major drug companies have embarked on a campaign to strangle supplies to Canadian Internet pharmacies, driving up the prices of drugs and frustrating American consumers looking for cheaper medicine north of the border.

From the (Phoenix) Arizona Republic:
Valley little affected by drug firms' tactics
Businesses that sell Canadian pharmaceuticals in the Valley say they haven't been affected by American drug manufacturers' efforts to stop the sale of prescription drugs from across the border.

From the Canadian Press:
U.S. Food and Drug Administration approves Biovail's Wellbutrin XL
Biovail Corp. has received approval from the U.S. Food and Drug Administration for its once-daily anti-depression drug Wellbutrin XL, the company said Friday.

From the New London (CT) Day:
Read The Warning Label First
H.L. Mencken, The Baltimore Sun's brightest star, noting the propensity of Congress to fix things that aren't broke, once sagely observed: “For every complex problem, there is an answer that is simple, neat and wrong.”